Return to       About vaccination against foot and mouth

 An FMD Expert Group has been established, to maintain an expertise in order to assist in ensuring preparedness against a disease outbreak.


61. Pre-outbreak the FMD Expert Group will meet on at least a six monthly basis.

62. In the event of an outbreak, the FMD Expert Group in some form will meet on a daily basis.

The FMD Expert Group will comprise:

Chair: Defra CVO/DCVO

FMD advice/consultation on clinical disease recognition IAH Pirbright
FMD virologist/diagnosis IAH Pirbright
FMD pathogenesis/pathology IAH Pirbright
FMD Vaccination IAH Pirbright
FMD Epidemiology Defra’s Consultant Epidemiologist
Meteorologist Met Office/IAH Pirbright
Serology VLA
Observer/link to Science Advisory Council Head of Veterinary Research Division, Defra
Epidemiologists SVS (HQ) Vets and other staff responsible for field epidemiology
Modelling representatives  
Veterinary representatives of the devolved administrations  

63. The expert group will be a strategic/tactical level group of specialists whose role will be to provide advice to senior management on surveillance programmes, analyse information and advise on control strategies. They will report to and be directed by the ADPG. In an outbreak the Expert Group will also have close links with the NEEG, the NDCC and the SAC-ED






48. The UK has its own stocks of 9 different strains of FMD antigen, adding up to over 20 million doses held on its behalf by a commercial supplier. In addition, the EU Vaccine Bank holds a wide range of antigens for emergency use. The number of doses available and strains is kept under review, including taking advice from IAH Pirbright on those strains of FMD which present the greatest risk to the UK. As soon as the FMD strain responsible for the outbreak is identified and it has been confirmed that one of the antigens held in the UK bank will afford protection, the supplier will be instructed to formulate vaccine. Vaccine formulation by the designated external contractor takes 4 days.



Update from IAH

3. The IAH representative advised that the new strain of FMDV that had been discovered in Egypt had not been eradicated and no vaccine with a good predicted match had been available to use in time. The EU had commissioned a study to look at the protection afforded by a readily available A Iraq vaccine strain. This study showed that despite the poor predicted match between this A strain and the new Egypt virus, the A vaccine could provide useful cross-protection provided that a very potent vaccine was used.

4. The new strain of serotype A that had been discovered in various Middle East countries including Turkey and regions close to the Bulgarian and Greek borders seemed to be controlled by use of an A22 Iraq vaccine.




























ARCHIVE 2001 -2007

Fields of Fire witness accounts of 2001

Foot and Mouth policy 2001 - opinions


Warmwell menu

FMD Front Page Current

General Archive Page (new window)

Archive August 2007 Surrey outbreak - stage 1

Archive July 2007

Archive June 2007

Archive May 2007

Archive April 2007

Archive March 2007

Archive February 2007

Archive January 2007

Archive December 2006

Archive November 2006

Archive October 2006

Archive September 2006

Archive August 2006

Archive July 2006

Archive June 2006

Archive May 2006

Archive April 2006

Archive March 2006

Archive February 2006

Archive January 2006

FMD Front Page September 2005 - Dec 2005

FMD Front Page Oct 2004 - August 2005

General Front Page (includes other and related items)

Front Page Autumn 2004

Front Page Summer - October 2004

Warmwell front pages Spring 2004

Warmwell front pages Oct 03 - Jan 04

Warmwell front pages Sept 2002

Warmwell front pages August 2002

Warmwell front pages June / July 2002

Warmwell front pages - May / June 2002

Warmwell front pages - April / May 2002

Warmwell front pages - March / April 2002

Warmwell front pages - the earliest pages in 2001 - March 2002